Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
life sciences
national blog main
national top stories
third rock ventures
2
×
acetylon pharmaceuticals
ally bridge group
ambys medicines
big data analytics
blackrock
boston
casdin capital
cell therapy
clinical trials
constellation pharmaceuticals
deals
diabetic nephropathy
eventide asset management
focal segmental glomerulosclerosis
gene therapy
genentech
goldfinch bio
holger willenbring
ipo
irving investors
jay ghosh
jeffrey tong
juan carlos izpisua belmonte
keith dionne
liver disease
markus grompe
martin burke
new york blog main
new york top stories
oregon stem cell center
proteon therapeutics
salk institute for biological studies
san diego blog main
What
biotech
diseases
2
×
medicines
2
×
new
aiming
ambys
analysis
big
bio
bring
company
control
deadly
deal
debuted
develop
drug
employing
formed
future
genetic
goldfinch
ipo
kidney
later
launch
lead
liver
make
million
raised
raises
startup
studies
takeda
today
treatments
unusual
variety
Language
unset
Current search:
medicines
×
diseases
×
" third rock ventures "
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
